Disciplined Investments, LLC Biomarin Pharmaceutical Inc Transaction History

Disciplined Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$87.74 - $117.27 $350 - $469	-4 Reduced 16.0%	21 $2,000
Q4 2022 Feb 01, 2023	BUY	$80.93 - $108.63 $80 - $108	1 Added 4.17%	25 $2,000
Q3 2022 Nov 03, 2022	BUY	$82.16 - $96.94 $410 - $484	5 Added 26.32%	24 $2,000
Q2 2022 Aug 09, 2022	BUY	$71.48 - $86.85 $142 - $173	2 Added 11.76%	19 $2,000
Q1 2022 Apr 22, 2022	BUY	$74.28 - $92.69 $1,262 - $1,575	17 New	17 $1,000

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.